SooAe Jones

Phase 2 trial of high‐dose rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non‐Hodgkin lymphoma

A. LaCasce, T. Batchelor, P. Armand, 2015, Cancer.

A Rapid Genotyping Panel for Detection of Primary Central Nervous System Lymphoma.

Matthew J. Frigault, D. Cahill, B. Nahed, 2021, Blood.

Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.

E. Wong, A. Norden, T. Batchelor, 2020, The oncologist.

Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens

P. Brastianos, J. Dietrich, Naema Nayyar, 2023, Neurology.